The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Genuine question - other than a bit of industry PR why would a bunch of conferences improve the SP?
4D upcoming news flow for the rest of the month.
Nasdaq listing plus:
*Chardan's Virtual 3rd Annual Microbiome Medicines Summit : Monday March 8, 2021 at 11:45 am ET (16:45 GMT).
*H.C. Wainwright Global Life Sciences Conference : Available on-demand starting Tuesday, March 9, 2021 at 7:00 am ET (12:00 GMT).
*Oppenheimer's 31(st) Annual Healthcare Conference : Tuesday, March 16, 2021 at 8:40 am ET (12:40 GMT).
4D are developing drugs for immuno oncology market in association with $200 bn Merck who sell $16bn of Keytruda p.a. Those metrics are rather imprtant imo.
https://www.pharmiweb.com/pwtoday-story/4d-pharma-appoints-john-beck-as-chief-financial-officer
Iamluving it - scrambler is making the comparison. I am simply correcting his/her assertion that the market cap here is half that of seres prior to their ph3 result. Seres was fully funded, and 4D will have a much higher share count by the time it is fully funded. ATB
You stated that seres had twice our market cap prior to their ph3. That is misleading people. Please stop. Seres was fully funded at the time. If/when we are fully funded, the 4D market cap will be much higher because the share count will rise considerably. I would guess at least as high as the Seres one prior to ph3 because we also have warrants and loac dilution to consider. This is not to debunk 4D - I own it - but to ensure people make informed decisions about how much they want to risk.
4d are way ahead with oncology and partnering up with some big pharmas. Seres phase 3 trial was for some hospital bug that is no comparison to being ahead in oncology. A different league.
As I said lots more chicken in the oven
Post Nasdaq launch will be " a good time to raise funds". Yes, of course, that is half the point of the exercise?! But the Exec will want that sp as high as possible before entertaining any significant dilution. They are shareholders too......
Seres also had $100m on the balance sheet. By the time 4D has $100m on the balance sheet the market cap here will have been diluted to the same level Seres was.
Many stocks have been suffering the last few days so not really a shock this has gone down. Part of the drop may be due to the hint ceo gave that the merger could also be a good time to raise funds - that’d be a share dilution.
Indeed PG. The only thing that has changed is the company has made further progress. Roll on Nasdaq.
Bear in mind...seres was twice our mcap before they had phase 3 trial results! 4D has more chicken in the oven!
have the fundamentals changed since you bought in? If they haven't then stick to your convictions.
This stock will very soon stop being dependent on the AIM casino.
I bought at 1.32 I did think that was a real good price but it just kept falling any reason I did not read anything that was concerning or did I miss something Thanks guys